IMMP: מזומנים בחישוב למניה אחת Immutep Corp

סמל ולוגו של המותג Immutep Limited (IMMP)

Immutep Limited develops advanced immunotherapy methods across centers in Europe and Australia. This chart from the GURU.Markets system displays liquid assets per share, where the value of 6.46 reflects the current solvency status. Immutep Limited aims for global expansion of its oncology pipeline through strategic alliances. Currently, the biotech sector is focused on the publication of LAG-3 protein trial results for the treatment of lung and breast cancer.

IMMP immutep.com: יתרות מזומנים למניה בטווח 04.07.2022 - 20.11.2026

פילוחים אנליטיים של חברת Immutep Limited

- מחיר ותחזית קונצנזוס למחירים:
- נתוני מזומנים ותזרימי מזומנים:
ניתוח מסכם של החברה:Immutep Limited
סחורת הדגל של immutep.com

This indicator reflects the amount of available cash per ordinary share, allowing for an assessment of the company's internal resources to cover obligations without resorting to external borrowing. By analyzing the level of liquid assets per share, an investor can gauge the financial autonomy of Immutep Limited (IMMP), which is critical for sustaining an organic R&D model and conducting large-scale clinical trials in partnership with pharmaceutical behemoths.